Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
you are here: HomeNewsWorld

How Europe sealed a Pfizer COVID-19 vaccine deal with texts and calls: Report

The deal will establish the European Union as Pfizer's biggest single client by far; the company has so far sold 300 million doses to the United States.

April 28, 2021 / 04:05 PM IST
Pfizer’s vaccine is based on genetic material or mRNA.

Pfizer’s vaccine is based on genetic material or mRNA.

It was February and things were going from bad to worse for the European Union’s vaccination campaign, and for its top executive, Ursula von der Leyen.

Much of Europe was in lockdown, people were dying, and the bloc was running low on doses of vaccines after its biggest supplier, AstraZeneca, announced production problems. Critics inside and outside the European Union questioned von der Leyen’s leadership and accused her of mishandling the crisis.

It was at that low point that she caught a break.

For a month, von der Leyen had been exchanging texts and calls with Albert Bourla, the chief executive of Pfizer, another vaccine supplier to the bloc. And as they spoke, two things became clear: Pfizer might have more doses it could offer the bloc — many more. And the European Union would be thrilled to have them.